TipRanks
Incannex Healthcare Limited Sponsored ADR (IXHL)
NASDAQ:IXHL
US Market
IXHL
Incannex Healthcare Limited Sponsored ADR
RESEARCH TOOLSreports
Want to see IXHL full AI Analyst Report?

Incannex Healthcare Limited Sponsored ADR (IXHL) Ratios

989 Followers

Incannex Healthcare Limited Sponsored ADR Ratios

IXHL's free cash flow for Q4 2026 was AU$0.00. For the 2026 fiscal year, IXHL's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Sep 24Jun 23
Liquidity Ratios
Current Ratio
 48.81 48.81 2.86 2.88 9.02
Quick Ratio
 48.81 48.81 2.86 2.88 9.02
Cash Ratio
 45.38 45.38 2.15 1.04 8.67
Solvency Ratio
 -3.40 -3.40 -6.61 -4.71 -16.47
Operating Cash Flow Ratio
 -5.52 -8.62 -1.79 -2.82 -4.22
Short-Term Operating Cash Flow Coverage
 -132.75 -207.53 -68.01 -97.21 0.00
Net Current Asset Value
AU$ 67.22M$ 67.22M$ 12.90M$ 10.37MAU$ 20.04M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.01 0.02 0.02
Debt-to-Equity Ratio
 <0.01 <0.01 0.02 0.03 0.03
Debt-to-Capital Ratio
 <0.01 <0.01 0.02 0.03 0.02
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 0.00 0.00 0.00
Financial Leverage Ratio
 1.08 1.08 1.53 1.52 1.14
Debt Service Coverage Ratio
 -367.53 -292.40 -44.74 -170.23 0.00
Interest Coverage Ratio
 0.00 0.00 -78.51 0.00 0.00
Debt to Market Cap
 <0.01 <0.01 0.02 <0.01 0.00
Interest Debt Per Share
 <0.01 <0.01 0.49 <0.01 <0.01
Net Debt to EBITDA
 2.97 2.97 0.63 0.20 1.59
Profitability Margins
Gross Profit Margin
0.00%0.00%-186.05%100.00%0.00%
EBIT Margin
0.00%0.00%-27661.63%-155058.33%0.00%
EBITDA Margin
0.00%0.00%-27375.58%-154200.00%0.00%
Operating Profit Margin
0.00%0.00%-27661.63%-250341.67%0.00%
Pretax Profit Margin
0.00%0.00%-56559.30%-153574.99%0.00%
Net Profit Margin
0.00%0.00%-54517.44%-153824.99%0.00%
Continuous Operations Profit Margin
0.00%0.00%-54517.44%-153824.99%0.00%
Net Income Per EBT
80.56%80.56%96.39%100.16%100.00%
EBT Per EBIT
104.05%104.05%204.47%61.35%357.90%
Return on Assets (ROA)
-26.45%-26.45%-229.30%-162.11%-205.23%
Return on Equity (ROE)
-27.42%-28.65%-350.18%-246.37%-234.39%
Return on Capital Employed (ROCE)
-32.21%-32.21%-176.70%-393.58%-64.23%
Return on Invested Capital (ROIC)
-32.18%-25.93%-168.02%-382.66%-63.89%
Return on Tangible Assets
-26.45%-26.45%-229.30%-162.11%-205.23%
Earnings Yield
-48.82%-44.03%-630.97%-5.80%-17.24%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.02 <0.01 0.00
Payables Turnover
 0.00 0.00 0.04 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.18 0.02 0.00
Asset Turnover
 0.00 0.00 <0.01 <0.01 0.00
Working Capital Turnover Ratio
 0.00 0.00 <0.01 <0.01 0.00
Cash Conversion Cycle
 0.00 0.00 10.62K 203.48K 0.00
Days of Sales Outstanding
 0.00 0.00 19.63K 203.48K 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 9.01K 0.00 0.00
Operating Cycle
 0.00 0.00 19.63K 203.48K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.67 -1.10 -10.90 -0.10 -0.07
Free Cash Flow Per Share
 -0.67 -1.10 -10.90 -0.10 -0.07
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.01 1.00 1.00 1.02 1.03
Dividend Paid and CapEx Coverage Ratio
 -124.74 -1.29K -1.56K -57.20 -34.02
Capital Expenditure Coverage Ratio
 -124.74 -1.29K -1.56K -57.20 -34.02
Operating Cash Flow Coverage Ratio
 -85.74 -134.03 -48.50 -42.48 -20.63
Operating Cash Flow to Sales Ratio
 0.00 0.00 -145.50 -881.98 0.00
Free Cash Flow Yield
-21.60%-29.38%-168.51%-3.38%-3.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -2.87 -2.27 -0.16 -17.25 -5.80
Price-to-Sales (P/S) Ratio
 0.00 0.00 86.40 26.54K 0.00
Price-to-Book (P/B) Ratio
 0.59 0.65 0.55 42.51 13.59
Price-to-Free Cash Flow (P/FCF) Ratio
 -4.63 -3.40 -0.59 -29.58 -25.58
Price-to-Operating Cash Flow Ratio
 -4.80 -3.41 -0.59 -30.09 -26.34
Price-to-Earnings Growth (PEG) Ratio
 -0.09 0.02 >-0.01 0.27 >-0.01
Price-to-Fair Value
 0.59 0.65 0.55 42.51 13.59
Enterprise Value Multiple
 1.28 1.04 0.31 -17.01 -19.30
Enterprise Value
 -29.21M -23.78M -7.35M 471.35M 261.49M
EV to EBITDA
 1.28 1.04 0.31 -17.01 -19.30
EV to Sales
 0.00 0.00 -85.47 26.24K 0.00
EV to Free Cash Flow
 3.52 1.85 0.59 -29.24 -23.63
EV to Operating Cash Flow
 3.55 1.85 0.59 -29.75 -24.33
Tangible Book Value Per Share
 5.47 5.78 11.66 0.07 0.14
Shareholders’ Equity Per Share
 5.47 5.78 11.66 0.07 0.14
Tax and Other Ratios
Effective Tax Rate
 0.00 0.19 0.04 >-0.01 0.00
Revenue Per Share
 0.00 0.00 0.07 <0.01 0.00
Net Income Per Share
 -1.57 -1.66 -40.82 -0.17 -0.32
Tax Burden
 0.81 0.81 0.96 1.00 1.00
Interest Burden
 1.04 1.04 2.04 0.99 3.58
Research & Development to Revenue
 0.00 0.00 124.97 1.07K 0.00
SG&A to Revenue
 0.00 0.00 152.65 1.33K 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 30.34 496.96 0.00
Income Quality
 0.64 0.67 0.27 0.86 0.22